---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-25-024625"
form_type: "8-K"
ticker: "WINT"
cik: "0000946486"
company_name: "WINDTREE THERAPEUTICS INC /DE/"
filed_at: "2025-08-04T23:59:59+00:00"
generated_at: "2026-05-17T21:43:11.155857+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Director Leanne Kelly resigns from Windtree board; Andrew Kucharchuk appointed as replacement and Audit Committee chair

## Summary
- Leanne Kelly resigned from Windtree Therapeutics board effective July 29, 2025; she had been Audit Committee chair.
- Andrew Kucharchuk appointed to board effective August 3, 2025, also appointed chair of Audit Committee.
- Kucharchuk is CFO of Cero Therapeutics Holdings and Chain Bridge I; previously CFO of Theralink Technologies.
- No material arrangements, transactions, or compensatory grants disclosed in connection with Kucharchuk's appointment.

## SEC filing metadata
- accession: 0001437749-25-024625
- form_type: 8-K
- ticker: WINT
- cik: 0000946486
- company_name: WINDTREE THERAPEUTICS INC /DE/
- filed_at: 2025-08-04T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/946486/000143774925024625/0001437749-25-024625-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/946486/000143774925024625/wint20250804_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-25-024625
- JSON: https://secwatch.observer/filing/0001437749-25-024625.json
- Plain text: https://secwatch.observer/filing/0001437749-25-024625.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.